ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1618

Prevalence of Inflammatory Sacroiliitis Assessed On MR Imaging of Inflammatory Bowel Disease: A Retrospective Study Performed On 186 Patients

Sophie Leclerc-Jacob1, Guillaume Lux2, Anne-Christine Rat1, Valérie Laurent2, Alain Blum2, Isabelle Chary-Valckenaere1, Laurent Peyrin-Biroulet3 and Damien Loeuille1, 1Rheumatology, Nancy Teaching Hospital, Nancy, France, 2Radiology, Nancy Teaching Hospital, Nancy, France, 3Gastroenterology and Hepatology, Nancy Teaching Hospital, Nancy, France

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: inflammatory bowel disease (IBD), Magnetic resonance imaging (MRI) and spondylarthropathy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases II: Magnetic Resonance Imaging

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Articular involvements are by far the most common extra-intestinal manifestations in inflammatory bowel disease (IBD). They include peripheral arthritis and inflammatory axial manifestation. Until now the prevalence of sacroiliitis in this same population was studied only on the structural plan. The main objective of this study was to estimate, for the first time, the prevalence of inflammatory sacroiliitis in IBD on digestive MRI defined according to ASAS (Assessment of SpondyloArthritis international Society) criteria. The secondary objective was to study the association between sacroiliitis and clinico-biological parameters in IBD.

Methods:

This study was performed on 186 patients suffering from IBD followed in a gastroenterology department between 2004 and 2011: 131 with Crohn’s disease (CD) (70.4%) and 55 with ulcerative colitis (UC) (29.6%). Clinico-biological and endoscopic data were collected and MR enterography or colonography was performed to assess IBD.

Two injected T1-weigthed sequences with fat saturation (FS) were used for the whole population: a coronal LAVA (liver acquisition with volume acceleration) sequence and an axial SPGR (spoiled gradient recalled) sequence. An additional injected axial LAVA sequence with FS was performed in 138 patients. On digestive MRI, sacroiliitis was scored blindly by two independent readers, a rheumatologist and a radiologist, according to ASAS criteria. The SIJ were graded bilateral, unilateral, normal and doubtful. In cases of discordance, the final diagnosis was obtained by consensus.

The association between sacroiliitis and the clinico-biological and radiological parameters of the digestive disease was analyzed by Fisher’s exact test or the chi-square test (qualitative variables) and by Wilcoxon’s test (quantitative variables) with a p value<0.05 as significant.

Results:

The prevalence of inflammatory sacroiliitis was 16.7% (31 patients). SIJ were considered as normal in 144 cases (77.4%) and doubtful in 11 cases (5.9%). Female gender in CD (p=0.01) and advanced age in both diseases (p=0.03) were associated with sacroiliitis on MRI. Disease duration tended to be associated with sacroiliitis (p=0.06), while other parameters such as the type of IBD, localization and extension of IBD, surgical history, biological inflammation, digestive activity, and type of treatment were not associated with sacroiliitis on digestive MRI.

Conclusion:

This study demonstrated for the first time the feasibility of using digestive MRI to establish the diagnosis of inflammatory sacroiliitis according to the ASAS criteria. Inflammatory sacroiliitis was evidenced by MRI in 1/6 patients suffering from IBD. This prevalence of sacroiliitis is probably underestimated due to technical and clinical factors (biologic treatment used). Added to clinico-biological data, MRI analysis should contribute to an earlier diagnosis of axial spondylarthritis in patients with IBD.


Disclosure:

S. Leclerc-Jacob,
None;

G. Lux,
None;

A. C. Rat,
None;

V. Laurent,
None;

A. Blum,
None;

I. Chary-Valckenaere,
None;

L. Peyrin-Biroulet,
None;

D. Loeuille,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-inflammatory-sacroiliitis-assessed-on-mr-imaging-of-inflammatory-bowel-disease-a-retrospective-study-performed-on-186-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology